Association between butyrylcholinesterase activity and low-grade systemic inflammation

被引:87
作者
Lampon, Natalia [1 ]
Hermida-Cadahia, Esperanza F. [1 ]
Riveiro, Alberto [2 ]
Carlos Tutor, J. [1 ]
机构
[1] Hosp Clin Univ, Inst Invest Sanitaria IDIS, Lab Cent, Unidad Monitorizac Farmacos, Santiago De Compostela 15706, Spain
[2] Hosp Clin Univ, Lab Cent, Secc Bioquim, Santiago De Compostela 15706, Spain
关键词
Butyrylcholinesterase; Albumin; High-sensitivity C-reactive protein; Procalcitonin; Low-grade systemic inflammation; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; GAMMA-GLUTAMYL-TRANSFERASE; METABOLIC SYNDROME; SERUM BUTYRYLCHOLINESTERASE; ALKALINE-PHOSPHATASE; INSULIN-RESISTANCE; FATTY LIVER; MORTALITY; DISEASE;
D O I
10.1016/S1665-2681(19)30932-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Pro-inflammatory cytokine production is directly inhibited by acetylcholine (ACh), and a relationship between total circulating ACh hydrolytic capacity and inflammatory reactions has been previously reported. Butyrylcholinesterase (BChE) is the major ACh hydrolyzing enzyme in plasma, and the aim of our study was to evaluate its association with low-grade systemic inflammation. Material and methods. A total of 4,077 patients clinically managed in the Cardiology, Hypertension, and Digestive Medicine Units were included in our study. Three subclinical chronic inflammatory degrees were established in accordance with the high-sensitivity C-reactive protein (hsCRP) concentrations proposed, for low (< 1 mg/L), average (1-3 mg/L), and high (> 3-10 mg/L) cardiovascular disease risk estimation. Results. In male patients with subclinical chronic inflammation and hsCRP concentrations < 1 mg/L, a significant positive correlation was observed between BChE and hsCRP (p < 0.02); however, for hsCRP concentrations > 3 mg/L, the correlation between these variables in both sexes becomes significantly negative (p < 0.001), as in patients with acute inflammation (hsCRP > 10 mg/L). In all cases significant positive correlations were obtained between the BChE activities and albumin concentrations (p < 0.001). Conclusions. The liver production of BChE and albumin occurs in a coupled fashion, and these biochemical variables may be considered as negative inflammatory reactants, whose serum levels are inversely associated with the increasing degree of subclinical inflammation.
引用
收藏
页码:356 / 363
页数:8
相关论文
共 42 条
  • [21] Mason Jennifer E, 2010, Prev Cardiol, V13, P36, DOI 10.1111/j.1751-7141.2009.00054.x
  • [22] Gamma-Glutamyl Transferase: The Silent Partner?
    Mistry, Dippica
    Stockley, Robert A.
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (04) : 285 - 290
  • [23] Regulation of cytochromes P450 during inflammation and infection
    Morgan, ET
    [J]. DRUG METABOLISM REVIEWS, 1997, 29 (04) : 1129 - 1188
  • [24] C-reactive protein: A pentraxin with anti-acetylcholine activity
    Nazarov, Peter G.
    Krylova, Irina B.
    Evdokimova, Natalia R.
    Nezhinskaya, Galina I.
    Butyugov, Alexander A.
    [J]. LIFE SCIENCES, 2007, 80 (24-25) : 2337 - 2341
  • [25] Nemesanszky E., 1996, ENZYME TEST DIAGNOSI
  • [26] SERUM-CHOLINESTERASE IN PATIENTS WITH FATTY LIVER
    NOMURA, F
    OHNISHI, K
    KOEN, H
    HIYAMA, Y
    NAKAYAMA, T
    ITOH, Y
    SHIRAI, K
    SAITOH, Y
    OKUDA, K
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1986, 8 (05) : 599 - 602
  • [27] Cholinergic status modulations in human volunteers under acute inflammation
    Ofek, Keren
    Krabbe, Karen S.
    Evron, Tama
    Debecco, Meir
    Nielsen, Anders R.
    Brunnsgaad, Helle
    Yirmiya, Raz
    Soreq, Hermona
    Pedersen, Bente K.
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (11): : 1239 - 1251
  • [28] Patocka Jiri, 2004, Acta Medica (Hradec Kralove), V47, P215
  • [29] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
    Pearson, TA
    Mensah, GA
    Alexander, RW
    Anderson, JL
    Cannon, RO
    Criqui, M
    Fadl, YY
    Fortmann, SP
    Hong, Y
    Myers, GL
    Rifai, N
    Smith, SC
    Taubert, K
    Tracy, RP
    Vinicor, F
    [J]. CIRCULATION, 2003, 107 (03) : 499 - 511
  • [30] Pugin J, 2011, GUIDE CLIN USE PROCA